Cargando…
Molecular assessment and the current limits of post-transplant prognostication for chronic myelomonocytic leukemia
Autores principales: | Gibson, Christopher J., Koreth, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827152/ https://www.ncbi.nlm.nih.gov/pubmed/35443568 http://dx.doi.org/10.3324/haematol.2022.280960 |
Ejemplares similares
-
Fighting back against chronic myelomonocytic leukemia
por: Jo, Deog-Yeon
Publicado: (2013) -
Juvenile Myelomonocytic Leukemia: Molecular Pathogenesis Informs Current Approaches to Therapy and Hematopoietic Cell Transplantation
por: Dvorak, Christopher C., et al.
Publicado: (2014) -
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016) -
Comparison of existing prognostic models in chronic myelomonocytic leukemia
por: Jian, Jin-Li, et al.
Publicado: (2020) -
Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)